Increasing the potential of cell-penetrating peptides for cancer therapy using a new pentagonal scaffold

Area of Science:

• Medicinal Chemistry
• Oncology
• Molecular Biology

Background:

• Cancer treatment remains a critical area of research, necessitating the development of more effective and safer therapeutic agents.
• Cell-penetrating peptides (CPPs) offer a promising platform for drug delivery, particularly in cancer therapy.

Purpose of the Study:

• To synthesize and characterize novel thiazole derivatives conjugated to CPP2, a cell-penetrating peptide known for its efficacy in colon cancer cells.
• To evaluate the antiproliferative and cytotoxic effects of these new conjugates on various cancer cell lines.

Main Methods:

• Synthesis and characterization of thiazole derivatives coupled to CPP2.
• Antiproliferative assays using 3H-thymidine incorporation in Caco-2 cells.
• Cytotoxicity assays measuring extracellular lactate dehydrogenase (LDH) activity in Caco-2, MCF-7, J774, L929, and THP1 cell lines.

Main Results:

• The BTZCA thiazole derivative conjugated to CPP2 (BTZCA-CPP2) demonstrated significant reduction in tumor cell viability and proliferation.
• BTZCA-CPP2 exhibited potential cytotoxic effects against human breast cancer MCF-7 cells.
• No significant cytotoxicity was observed for the new derivatives or CPP2 alone across J774, L929, and THP1 cell lines.

Conclusions:

• Novel thiazole-CPP2 conjugates show promise as potential anticancer agents, particularly BTZCA-CPP2.
• The developed compounds exhibit targeted antiproliferative activity with a favorable safety profile.
• Future research could explore conjugating smaller CPPs with these thiazole derivatives for enhanced drug development in cancer therapy.